icig 1163 has been researched along with Leukemia L 1210 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayat, M; Jasmin, C; MacDonald, JS; Mathé, G; Mori, KJ | 1 |
| Bourut, C; Chenu, E; Hayat, M; Imbach, JL; MacDonald, JS; Mathé, G; Montero, JL | 1 |
2 other study(ies) available for icig 1163 and Leukemia L 1210
| Article | Year |
|---|---|
In vivo study of acute hematotoxicity of three nitrosoureas, chlorozotocin (chloro-2-ethyl)-ribofuranosyl-3-nitrosourea, and (chloro-2-ethyl)-1-ribopyranosyl-3-nitrosourea.
Topics: Animals; Bone Marrow; Colony-Forming Units Assay; Hematopoietic Stem Cells; Leukemia L1210; Leukocyte Count; Male; Mice; Nitrosourea Compounds; Spleen; Streptozocin | 1980 |
Comparative pharmacology of three new nitrosourea analogues: RFCNU, RPCNU, and chlorozotocin. I. Oncostatic effects in mice.
Topics: Animals; Antineoplastic Agents; Half-Life; Humans; Lethal Dose 50; Leukemia L1210; Male; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Nitrosourea Compounds; Streptozocin | 1979 |